These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9415568)

  • 21. Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity.
    Kozima Y; Urano T; Serizawa K; Takada Y; Takada A
    Thromb Res; 1993 Apr; 70(2):191-202. PubMed ID: 8322287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood coagulation, fibrinolytic and inhibitory profiles in renal transplant recipients: comparison of cyclosporine and azathioprine.
    Vaziri ND; Ismail M; Martin DC; Gonzales E
    Int J Artif Organs; 1992 Jun; 15(6):365-9. PubMed ID: 1639529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ; Krikun G; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
    Hu XY; Ma YH; Wang C; Yang YH
    Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression.
    Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J
    Nephron; 1999; 82(3):238-45. PubMed ID: 10395996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
    Erdem Y; Usalan C; Haznedaroğlu IC; Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1071-6. PubMed ID: 10604482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
    J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation and fibrinolytic parameters in patients with pulmonary hypertension.
    Altman R; Scazziota A; Rouvier J; Gurfinkel E; Favaloro R; Perrone S; Fareed J
    Clin Cardiol; 1996 Jul; 19(7):549-54. PubMed ID: 8818435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with everolimus is associated with a procoagulant state.
    Baas MC; Gerdes VE; Ten Berge IJ; Heutinck KM; Florquin S; Meijers JC; Bemelman FJ
    Thromb Res; 2013 Aug; 132(2):307-11. PubMed ID: 23906938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinolytic pattern in recurrent spontaneous abortions: no relationship between hypofibrinolysis and anti-phospholipid antibodies.
    Patrassi GM; Sartori MT; Ruffatti A; Viero M; Di Lenardo L; Cazzanello D; Ghirardello A; Boeri G; Saggiorato G; Girolami A
    Am J Hematol; 1994 Dec; 47(4):266-72. PubMed ID: 7977298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
    Gajarski RJ; Smith EO; Denfield SW; Rosenblatt HM; Kearney D; Frazier OH; Radovancevic B; Price JK; Kertesz NJ; Towbin JA
    Transplantation; 1998 Jun; 65(11):1470-6. PubMed ID: 9645805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the fibrinolytic system in myocardial infarction].
    Moreno JA; Cornudella R; Gálvez M; Angós JA; Romero S; Gutiérrez M
    Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ; Boon GI; Jansen JW; Bouma BN
    Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.